Dellinger R P, Levy M M, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012[J]. Intensive Care Med, 2013, 39(2): 165-228. [2]高戈, 冯？, 常志刚, 等. 2012国际严重脓毒症及脓毒性休克诊疗指南[J]. 中华危重病急救医学, 2013, 25(8): 501-505. [3]Moore L J, McKinley B A, Turner K L, et al. The epidemiology of sepsis in general surgery patients[J]. J Trauma, 2011, 70(3): 672-680. [4]Klein-Klouwenberg P M, Ong D S, Bonten M J, et al. Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria[J]. Intensive Care Med, 2012, 38(5): 811-819. [5]Barochia A, Solomon S, Cui X, et al. Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies[J]. Expert Opin Drug Metab Toxicol, 2011, 7(4): 479-494. [6]Rudiger A, Singer M. The heart in sepsis: from basic mechanisms to clinical management[J]. Curr Vasc Pharmacol, 2013, 11(2): 187-195. [7]Zanotti-Cavazzoni S L, Hollenberg S M. Cardiac dysfunction in severe sepsis and septic shock[J]. Curr Opin Crit Care, 2009, 15(5): 392-397. [8]Omar A A, El-Shahat N, Ramadan M M. Cardiac functions in patients with sepsis and septic shock[J]. The Egyptian Heart Journal, 2012, 64(4): 191-196. [9]Pan C S, Yang J H, Cai D Y, et al. Cardiovascular effects of newly discovered peptide intermedin/adrenomedullin 2[J]. Peptides, 2005, 26(9): 1640-1646. [10]Zhao L, Peng D Q, Zhang J, et al. Extracellular signal-regulated kinase 1/2 activation is involved in intermedin1 53 attenuating myocardial oxidative stress injury induced by ischemia/reperfusion[J]. Peptides, 2012, 33(2): 329-335. [11]Li H, Bian Y, Zhang N, et al. Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats[J]. Cardiovas Diabetol, 2013, 12: 91.
[2]
刘红云,王建春.CD200/CD200R在大鼠脓毒症急性肺损伤中的表达[J].第三军医大学学报,2012,34(15):1487. Liu Hongyun,Wang Jianchun.Expression profiles of CD200/CD200R in rat septic acute lung injury[J].J Third Mil Med Univ,2012,34(07):1487. [2]杨东,张瑛,郑新川,等.白鲜皮生物碱抗内毒素活性的研究[J].第三军医大学学报,2012,34(20):2097. Yang Dong,Zhang Ying,Zheng Xinchuan,et al.Anti-lipopolysaccharide activity of alkaloid components from Densefruit pittany root-bark[J].J Third Mil Med Univ,2012,34(07):2097. [3]刘占国,谭晓莹,蔡靓,等.脓毒症患者危重程度与血清IL-6的相关性分析[J].第三军医大学学报,2012,34(21):2233. [4]陈露露,徐关丽,袁红梅,等.龙胆苦苷对脓毒症所致急性肺损伤小鼠的保护作用[J].第三军医大学学报,2012,34(23):2392. Chen Lulu,Xu Guanli,Yuan Hongmei,et al.Protection of gentiopicroside on acute lung injury in sepsis mice[J].J Third Mil Med Univ,2012,34(07):2392. [5]周红,刘鑫,郑江.脓毒症治疗――挑战与机遇并存[J].第三军医大学学报,2013,35(02):91. Zhou Hong,Liu Xin,Zheng Jiang.Sepsis treatment――Challenge and chance[J].J Third Mil Med Univ,2013,35(07):91. [6]王松柏,裴树俊,徐昌富,等.JAK抑制剂AG490对大鼠组织iNOS和NO合成的影响[J].第三军医大学学报,2007,29(15):1511. WANG Song-bai,PEI Shu-jun,XU Chang-fu,et al.Effects of janus kinase/signal transducer and activator of transcription pathway on synthesis of iNOS and NO in pulmonary and vascular tissues of infectious shock rats[J].J Third Mil Med Univ,2007,29(07):1511. [7]曹红卫,郭毅斌,魏利召,等.青蒿素对脓毒症大鼠肺损伤的保护作用[J].第三军医大学学报,2007,29(10):951. CAO Hong-wei,GUO Yi-bin,WEI Li-zhao,et al.Effect of artemisinin on lung injury in septic rats[J].J Third Mil Med Univ,2007,29(07):951. [8]周凤桐,陶国才,王松柏,等.感染性休克大鼠JAK/STAT对组织IFN-γ表达的影响[J].第三军医大学学报,2006,28(15):1585. [9]李保胜,崔社怀,吕凤林,等.C5a反义肽对实验性脓毒症小鼠肺损伤的作用研究[J].第三军医大学学报,2006,28(09):932. [10]王晓娟,刘德贵,杨勇,等.IL-15改善铜绿假单胞杆菌脓毒症小鼠的免疫抑制[J].第三军医大学学报,2011,33(17):1834. Wang Xiaojuan,Liu Degui,Yang Yong,et al.Effect of IL-15 on immunosuppression of mice with sepsis caused by Pseudomonas aeruginosa[J].J Third Mil Med Univ,2011,33(07):1834.
